Division of AIDS (DAIDS)

HIV/AIDS Clinical Trials Networks

The NIAID HIV/AIDS Clinical Trials Networks have been designed to address one or more of NIAID’s six high priority areas of research:

1. Vaccine Research and Development (HVTN)
2. Translational Research/Drug Development (ACTG, IMPAACT)
3. Optimization of Clinical Management, Including Co-Morbidities (ACTG, IMPAACT, INSIGHT)
4. Microbicides (MTN)
5. Prevention of Mother-to-Child Transmission of HIV (IMPAACT)
6. Prevention of HIV Infection (HVTN, HPTN)

AIDS Clinical Trials Group (ACTG)

• Principal Investigator: Dan Kuritzkes, M.D.
• Primary research focus: optimizing clinical management of HIV/AIDS including, co-infections and other HIV-related conditions, and conducting translational research for new drug development

HIV Prevention Trials Network (HPTN)

• Principal Investigator: Sten Vermund, M.D., Ph.D.
• Primary research focus: evaluating non-vaccine HIV prevention strategies

HIV Vaccine Trials Network (HVTN)

• Principal Investigator: Lawrence Corey, M.D.
• Primary research focus: evaluating preventive HIV vaccines

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT)

• Principal Investigator: Jay Brooks Jackson, M.D., M.B.A.
• Primary research focus: preventing mother to child transmission of HIV, optimizing clinical management of HIV, including co-morbidities and other HIV-related conditions in children, adolescents and pregnant women

International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)

• Principal Investigator: James D. Neaton, Ph.D.
• Primary research focus: optimizing clinical management of HIV/AIDS, including co-infections and other HIV-related conditions

Microbicide Trials Network (MTN)

• Principal Investigator: Sharon Hillier, Ph.D.
• Primary research focus: evaluating microbicides for HIV prevention

back to top